As US measles cases rise, biotech firms start developing new treatments

The US is making measles great again, so treatment options are needed for the most vulnerable. https://arstechnica.com/health/2026/07/as-us-measles-cases-rise-biotech-firms-start-developing-new-treatments/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social